drugset / Trial / NCT04816071
Essential Amino Acid Supplementation in Older Adult COVID-19 Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
A 4-week treatment of essential amino acids or placebo to participants with: 1) negative COVID-19 test with exposure, or 2) positive COVID-19 test and no or mild symptoms. The study team will measure change in symptoms. Participants will complete symptom surveys for 4 weeks and once at 8 and 12 weeks as well as pre- and post-assessments.
Timeline
- Start
- 2021-05-01
- Primary completion
- 2021-05-01
- Completion
- 2021-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Essential Aminoacids | Unknown | 18 g | — |